TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 44 filers reported holding TRANSPHORM INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,340,676 | -34.7% | 22,675,980 | 0.0% | 1.77% | -25.9% |
| Q2 2023 | $77,098,332 | -14.8% | 22,675,980 | 0.0% | 2.39% | -12.3% |
| Q1 2023 | $90,477,160 | -26.7% | 22,675,980 | 0.0% | 2.72% | -34.6% |
| Q4 2022 | $123,357,331 | +8.2% | 22,675,980 | 0.0% | 4.16% | +81.7% |
| Q3 2022 | $114,060,000 | +32.0% | 22,675,980 | 0.0% | 2.29% | +99.4% |
| Q2 2022 | $86,395,000 | -44.9% | 22,675,980 | +2.3% | 1.15% | -19.2% |
| Q1 2022 | $156,784,000 | – | 22,175,980 | – | 1.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|